Solid Tumors Clinical Trials

ReadTheTrial indexes 5 studies for Solid Tumors. The most common development stage is Phase 2 (3 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

5 clinical trials found for Solid Tumors.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 3
60%
Phase 3 1
20%
Phase 1 1
20%

Trial Status Breakdown

Trials for Solid Tumors

Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)

NCT07415031 · NOT YET RECRUITING · Phase 2

PROCEADE PanTumor: A Phase 1b/2, Multicenter, Open-Label Study of Anti-CEACAM5 Antibody-Drug Conjugate M9140 in Participants With Advanced Solid Tumors (Master Protocol)

NCT06710132 · RECRUITING · Phase 2

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial

NCT04589845 · ACTIVE NOT RECRUITING · Phase 2

An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies

NCT03815643 · ACTIVE NOT RECRUITING · Phase 3

A Phase I Study of Autologous Activated Natural Killer (NK) Cells +/- rhIL15 in Children and Young Adults With Refractory Solid Tumors

NCT01875601 · COMPLETED · Phase 1

Frequently Asked Questions

What clinical trials are available for Solid Tumors?

There are 5 clinical trials listed for Solid Tumors. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Solid Tumors trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Solid Tumors trials in?

Current Solid Tumors trials are distributed across: Phase 2 (3), Phase 3 (1), Phase 1 (1).

Find More Trials